Browsing by Author Dobrovic, Alexander N

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)Citation
2013Docetaxel plus cetuximab as second-line treatment for docetaxel-refractory oesophagogastric cancer: the AGITG ATTAX2 trialGebski, Val; Parry, M M; Pavlakis, Nick; Zannino, Diana; Dobrovic, Alexander N; Ganju, V.; Mellor, D; Strickland, A. H.; Tebbutt, Niall C; van Hazel, Guy; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentreDocetaxel plus cetuximab as second-line treatment for docetaxel-refractory oesophagogastric cancer: the AGITG ATTAX2 trial, British Journal of Cancer, vol.108, 4, 2013,pp 771-774
2015Multicenter randomized, open-label phase II trial of sequential erlotinib and gemcitabine compared with gemcitabine monotherapy as first-line therapy in elderly or ECOG PS two patients with advanced NSCLCClarke, Stephen; Abdi, E; Button, Peter; Clingan, Philip R.; Do, Hongdo; Dobrovic, Alexander N; Gregory, Daniel; Michael, Michael; Nott, Louise M; Solomon, Benjamin; White, Shane C; Zimet, A; Northern Clinical School: Kolling InstituteMulticenter randomized, open-label phase II trial of sequential erlotinib and gemcitabine compared with gemcitabine monotherapy as first-line therapy in elderly or ECOG PS two patients with advanced NSCLC, Asia-Pacific Journal of Clinical Oncology, vol.11, 1, 2015,pp 4-14